As one of the first steps in many NGS data analysis pipelines, accurate variant calling is often critical to downstream analysis and interpretation. Here, we take a look at variant calling best practice through a modern lens.
Read articleAs one of the first steps in many NGS data analysis pipelines, accurate variant calling is often critical to downstream analysis and interpretation. Here, we take a look at variant calling best practice through a modern lens.
ReadA high-quality sequencing library is the linchpin to generating good sequencing data. We discuss our six top tips to help you improve your sequencing library.
ReadWe discuss the development and current state of sequencing technologies, and where the future of NGS may take us...
ReadFISH is a cytogenetic technique utilized in labs to detect chromosomal abnormalities in both cancer and constitutional specimens. In this blog learn about the advantages of FISH...
ReadThis blog will discuss FLT3’s normal function, its implications in myeloid malignancies, and the role of NGS in genetic identification and disease management of patients with FLT3 genetic alterations.
ReadWhile liquid biopsy may present an attractive alternative to a solid biopsy, it also has limitations. Here, we shed light on some advantages, limitations, and future outlook for liquid biopsy in oncology clinical practice.
ReadWith many of our team once being customers themselves, our scientists endeavor to create a portfolio shaped by a genuine understanding of its real-world clinical application. Meet Jackie Chan and Huiyan Jin, two of OGT’s Next Generation Sequencing (NGS) experts.
ReadRich and Tori explain how their combined 40 years of experience in clinical diagnostics has been invaluable in helping them to support their customers.
ReadFind out about the benefits and differentiating factors of the three most commonly used NGS technologies; targeted gene panels, whole-exome sequencing (WES) and whole-genome sequencing (WGS).
ReadFind out how OGT's European Field Application Specialists have been finding resourceful ways to support customers during the COVID shutdown.
ReadFind out how OGT's North American Field Application Scientists have been finding resourceful ways to support customers during the COVID shutdown.
ReadCarmen Vokaty, Assistant-Chief Medical Technologist in Cytogenetics at the McGill University Health Centre, details how her lab incorporated OGT’s Cytocell Tissue Pretreatment kit into its workflow after struggling with a homebrew solution.
Read
